companydata.dkcompanydata.dk

Ascendis Pharma Oncology Division A/S: Financial statements 2022

CVR: 41034076

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

Ascendis Pharma Oncology Division A/S (CVR 41034076) has filed annual accounts for 2022. In 2022, the company reported a gross profit of EUR -62,367,388 and a net result of EUR -64,912,248 compared with EUR -47,980,231 the year before. Equity in the 2022 report amounted to EUR -141,020,898.

Gross Profit
EUR -62,367,388
Profit/Loss
EUR -64,912,248
Equity
EUR -141,020,898
Total Assets
EUR 5,604,077
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022--62.4M EUR-64.9M EUR-141M EUR0
2021--46.7M EUR-48M EUR-76.1M EUR0
2020--35.7M EUR-36.1M EUR-28.1M EUR0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Ascendis Pharma Oncology Division A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Ascendis Pharma Oncology Division A/S: The 2021 annual report is outMay 9, 2022

Ascendis Pharma Oncology Division A/S has published its annual report for 2021. Gross profit came to DKK -46,676,711, and the net result was DKK -47,980,231.

About Ascendis Pharma Oncology Division A/S

Ascendis Pharma Oncology Division A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Jan Møller Mikkelsen. The board consists of Michael Wolff Jensen (chair), Anni Lotte Kirstine Pedersen and Jan Møller Mikkelsen. The company is owned by ASCENDIS PHARMA A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of EUR -85,226,000 and a net result of EUR -110,131,000 compared with EUR -106,375,000 the year before. Equity in the 2025 report amounted to EUR -501,637,000.

Source: annual report 2025, Danish Business Authority

Other financial years